ACASTI PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.96 USD | -4.52% |
|
-10.09% | +2.42% |
| 21/06 | Acasti Pharma Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| 28/05 | Acasti Pharma Inc. to Attend BIO International Convention 2024 | CI |
Chart calendar Acasti Pharma Inc.
aa6.QtXY-GLL9674C6nkHjn-IgOQ7yqVX2UlNNMzciRan3s.M5aBkgiSsdm_P5qIKFy2D0ClinL0KFxPV5l0F2kK1gkgpLyTEJi2xrA6_A~388890c045ef675002072f93e18da1fe
Upcoming events on Acasti Pharma Inc.
Past events on Acasti Pharma Inc.
| 21/06/2024 09:51 pm | Q4 2024 Earnings Release |
| 03/06/2024 | BIO International Convention Conference |
| 12/02/2024 06:30 pm | Q3 2024 Earnings Release |
| 08/02/2024 | International Stroke Conference |
| 10/01/2024 | LifeSci Partners Corporate Access Event |
| 08/01/2024 | Bio One On One Partnering Conference |
| 07/01/2024 | Sachs Neuroscience Innovation Forum |
| 13/11/2023 06:30 pm | Q2 2024 Earnings Release |
| 11/10/2023 11:30 pm | Investor Meeting - Key Openion Leader |
| 10/10/2023 10:30 pm | Annual General Meeting |
| 11/09/2023 11:30 pm | H.C. Wainwright Global Investment Conference |
| 17/08/2023 03:30 am | Neurocritical Care Society Meeting - Poster Number: 247 |
| 11/08/2023 04:30 pm | Q1 2024 Earnings Release |
| 23/06/2023 04:30 pm | Q4 2023 Earnings Release |
| 18/05/2023 11:30 pm | Lytham Partners Spring Investor Conference - Panel |
| 18/05/2023 06:30 pm | Lytham Partners Spring Investor Conference |
| 13/03/2023 06:10 pm | Oppenheimer Healthcare Conference |
| 14/02/2023 11:30 pm | Q3 2023 Earnings Call |
| 14/02/2023 05:30 pm | Q3 2023 Earnings Release |
| 31/01/2023 07:30 pm | Lytham Partners virtual Investor Select Conference |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 -18,9 - | -22,1 |
|
EBIT Million CAD | Released Forecast Spread | -30,6 -35,9 14.87% | 0,00 | -20,3 -21,5 5.92% | -24,6 -27,2 9.74% | -15,6 -16,3 4.14% | -23,4 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -34,9 -68,1 48.68% | 0,00 | -13,6 -14,9 8.76% | -68,4 -27,2 -151.55% | -20,1 -19,6 -2.64% | -23,4 |
|
Net income Million CAD | Released Forecast Spread | -34,9 -68,1 48.68% | -24,3 | -12,8 -14,9 14.41% | -55,9 -26,3 -112.7% | -17,6 -18,4 4.26% | -23,4 |
|
EPS CAD | Released Forecast Spread | -19,7 -38,2 48.43% | -10,1 | -2,09 -1,07 -96.04% | -7,53 -3,56 -111.24% | -1,85 -1,94 4.32% | -1,49 |
| Announcement Date | 29/06/20 | 22/06/21 | 21/06/22 | 23/06/23 | 21/06/24 | - |
Quarterly results
| Fiscal Period | März | 2022 Q4 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -4,10 -3,24 -26.37% | -4,97 | -4,51 | -5,87 | -5,87 | -5,87 | -5,46 | |||||
|
EBIT Million CAD | Released Forecast Spread | -5,72 -7,64 25.15% | -5,67 -7,79 27.27% | -6,01 -8,44 28.8% | -5,97 -6,63 10% | -2,89 -3,27 11.46% | -4,10 -3,51 -16.69% | -4,47 -5,38 16.76% | -4,92 | -6,15 | -6,15 | -6,15 | -5,46 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -5,91 -7,64 22.62% | -5,56 -7,86 29.25% | -50,0 -8,44 -491.99% | -5,78 -6,40 9.67% | -5,14 -3,10 -66.12% | -3,50 -3,51 0.34% | -5,56 -5,38 -3.44% | -4,92 | -6,15 | -6,15 | -6,15 | -5,46 |
|
Net income Million CAD | Released Forecast Spread | -5,07 -7,64 33.64% | -5,19 -7,74 32.92% | -38,3 -8,44 -353.64% | -5,39 -6,21 13.13% | -4,53 -3,00 -50.7% | -3,22 -3,55 9.42% | -4,34 -5,38 19.24% | -4,92 | -6,15 | -6,15 | -6,15 | -5,46 |
|
EPS CAD | Released Forecast Spread | -0,31 -1,00 68.86% | -0,72 -1,02 29.25% | -5,15 -1,13 -356.66% | -0,72 -0,84 13.44% | -0,59 -0,40 -50.59% | -0,28 -0,31 9.09% | -0,36 -0,47 24.14% | -0,34 | -0,42 | -0,42 | -0,33 | -0,29 |
| Announcement Date | 21/06/22 | 14/02/23 | 23/06/23 | 11/08/23 | 13/11/23 | 12/02/24 | 21/06/24 | - | - | - | - | - |
More events
Past sector events for Acasti Pharma Inc.
| 21/06/2024 08:58 pm | DEVA HOLDING: Q1 2024 Earnings Release |
| 14/06/2024 02:51 am | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 11/06/2024 11:00 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/06/2024 04:03 pm | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 07/06/2024 02:47 pm | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 30/05/2024 05:38 pm | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 11:54 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 05:30 pm | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 02:56 pm | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACST Stock
- Calendar Acasti Pharma Inc.
